Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
American Journal of Obstetrics and Gynecology
|
January 1, 1982
An evaluation of two equations for predicting fetal weight by ultrasound
M J Shepard, V A Richards, R L Berkowitz, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 1990
Radiation therapy for gliomas of the optic nerve and chiasm
J J Kovalic, P W Grigsby, M J Shepard, et al.
Radiology
|
October 1, 1994
Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia
R J Jackman, K W Nowels, M J Shepard, et al.
Radiology
|
April 20, 1999
Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up
R J Jackman, K W Nowels, J Rodriguez-Soto, et al.
The New England Journal of Medicine
|
May 17, 1990
A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study
M B Bracken, M J Shepard, W F Collins, et al.
JAMA
|
January 6, 1984
Efficacy of methylprednisolone in acute spinal cord injury
M B Bracken, W F Collins, D F Freeman, et al.
Journal of Neurosurgery
|
January 11, 1992
Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study
M B Bracken, M J Shepard, W F Collins, et al.
Journal of Neurosurgery
|
November 1, 1985
Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study
M B Bracken, M J Shepard, K G Hellenbrand, et al.
The Journal of Trauma
|
April 1, 2000
Clinical measurement, statistical analysis, and risk-benefit: controversies from trials of spinal injury
M B Bracken, E F Aldrich, D L Herr, et al.
JAMA
|
May 28, 1997
Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study
M B Bracken, M J Shepard, T R Holford, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
American Journal of Obstetrics and Gynecology
|
January 1, 1982
An evaluation of two equations for predicting fetal weight by ultrasound
M J Shepard, V A Richards, R L Berkowitz, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 1990
Radiation therapy for gliomas of the optic nerve and chiasm
J J Kovalic, P W Grigsby, M J Shepard, et al.
Radiology
|
October 1, 1994
Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia
R J Jackman, K W Nowels, M J Shepard, et al.
Radiology
|
April 20, 1999
Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up
R J Jackman, K W Nowels, J Rodriguez-Soto, et al.
The New England Journal of Medicine
|
May 17, 1990
A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study
M B Bracken, M J Shepard, W F Collins, et al.
JAMA
|
January 6, 1984
Efficacy of methylprednisolone in acute spinal cord injury
M B Bracken, W F Collins, D F Freeman, et al.
Journal of Neurosurgery
|
January 11, 1992
Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study
M B Bracken, M J Shepard, W F Collins, et al.
Journal of Neurosurgery
|
November 1, 1985
Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study
M B Bracken, M J Shepard, K G Hellenbrand, et al.
The Journal of Trauma
|
April 1, 2000
Clinical measurement, statistical analysis, and risk-benefit: controversies from trials of spinal injury
M B Bracken, E F Aldrich, D L Herr, et al.
JAMA
|
May 28, 1997
Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study
M B Bracken, M J Shepard, T R Holford, et al.
Page
of 3